The Influence of Pubertal Development on Autoantibody Appearance and Progression to Type 1 Diabetes in the TEDDY Study

Abstract Context The 2 peaks of type 1 diabetes incidence occur during early childhood and puberty. Objective We sought to better understand the relationship between puberty, islet autoimmunity, and type 1 diabetes. Methods The relationships between puberty, islet autoimmunity, and progression to ty...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of the Endocrine Society Ročník 8; číslo 7; s. bvae103
Hlavní autoři:	Warncke, Katharina, Tamura, Roy, Schatz, Desmond A, Veijola, Riitta, Steck, Andrea K, Akolkar, Beena, Hagopian, William, Krischer, Jeffrey P, Lernmark, Åke, Rewers, Marian J, Toppari, Jorma, McIndoe, Richard, Ziegler, Anette-G, Vehik, Kendra, Haller, Michael J, Elding Larsson, Helena
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	US Oxford University Press 01.07.2024
Témata:	Autoantibodies Clinical Clinical Medicine Development and progression Diabetes Endocrinology and Diabetes Endokrinologi och diabetes Health aspects Islands of Langerhans Klinisk medicin Medical and Health Sciences Medicin och hälsovetenskap Pediatric research Physiological aspects Puberty Type 1 diabetes Germany type 1 diabetes β-cell diabetes insulin resistance
ISSN:	2472-1972, 2472-1972
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	Abstract Context The 2 peaks of type 1 diabetes incidence occur during early childhood and puberty. Objective We sought to better understand the relationship between puberty, islet autoimmunity, and type 1 diabetes. Methods The relationships between puberty, islet autoimmunity, and progression to type 1 diabetes were investigated prospectively in children followed in The Environmental Determinants of Diabetes in the Young (TEDDY) study. Onset of puberty was determined by subject self-assessment of Tanner stages. Associations between speed of pubertal progression, pubertal growth, weight gain, homeostasis model assessment of insulin resistance (HOMA-IR), islet autoimmunity, and progression to type 1 diabetes were assessed. The influence of individual factors was analyzed using Cox proportional hazard ratios. Results Out of 5677 children who were still in the study at age 8 years, 95% reported at least 1 Tanner Stage score and were included in the study. Children at puberty (Tanner Stage ≥2) had a lower risk (HR 0.65, 95% CI 0.45-0.93; P = .019) for incident autoimmunity than prepubertal children (Tanner Stage 1). An increase of body mass index Z-score was associated with a higher risk (HR 2.88, 95% CI 1.61-5.15; P < .001) of incident insulin autoantibodies. In children with multiple autoantibodies, neither HOMA-IR nor rate of progression to Tanner Stage 4 were associated with progression to type 1 diabetes. Conclusion Rapid weight gain during puberty is associated with development of islet autoimmunity. Puberty itself had no significant influence on the appearance of autoantibodies or type 1 diabetes. Further studies are needed to better understand the underlying mechanisms.
AbstractList	Context The 2 peaks of type 1 diabetes incidence occur during early childhood and puberty. Objective We sought to better understand the relationship between puberty, islet autoimmunity, and type 1 diabetes. Methods The relationships between puberty, islet autoimmunity, and progression to type 1 diabetes were investigated prospectively in children followed in The Environmental Determinants of Diabetes in the Young (TEDDY) study. Onset of puberty was determined by subject self-assessment of Tanner stages. Associations between speed of pubertal progression, pubertal growth, weight gain, homeostasis model assessment of insulin resistance (HOMA-IR), islet autoimmunity, and progression to type 1 diabetes were assessed. The influence of individual factors was analyzed using Cox proportional hazard ratios. Results Out of 5677 children who were still in the study at age 8 years, 95% reported at least 1 Tanner Stage score and were included in the study. Children at puberty (Tanner Stage ≥2) had a lower risk (HR 0.65, 95% CI 0.45-0.93; P = .019) for incident autoimmunity than prepubertal children (Tanner Stage 1). An increase of body mass index Z-score was associated with a higher risk (HR 2.88, 95% CI 1.61-5.15; P < .001) of incident insulin autoantibodies. In children with multiple autoantibodies, neither HOMA-IR nor rate of progression to Tanner Stage 4 were associated with progression to type 1 diabetes. Conclusion Rapid weight gain during puberty is associated with development of islet autoimmunity. Puberty itself had no significant influence on the appearance of autoantibodies or type 1 diabetes. Further studies are needed to better understand the underlying mechanisms. Context: The 2 peaks of type 1 diabetes incidence occur during early childhood and puberty. Objective: We sought to better understand the relationship between puberty, islet autoimmunity, and type 1 diabetes. Methods: The relationships between puberty, islet autoimmunity, and progression to type 1 diabetes were investigated prospectively in children followed in The Environmental Determinants of Diabetes in the Young (TEDDY) study. Onset of puberty was determined by subject selfassessment of Tanner stages. Associations between speed of pubertal progression, pubertal growth, weight gain, homeostasis model assessment of insulin resistance (HOMA-IR), islet autoimmunity, and progression to type 1 diabetes were assessed. The influence of individual factors was analyzed using Cox proportional hazard ratios. Results: Out of 5677 children who were still in the study at age 8 years, 95% reported at least 1 Tanner Stage score and were included in the study. Children at puberty (Tanner Stage [greater than or equal to] 2) had a lower risk (HR 0.65, 95% CI 0.45-0.93; P = .019) for incident autoimmunity than prepubertal children (Tanner Stage 1). An increase of body mass index Z-score was associated with a higher risk (HR 2.88, 95% CI 1.61-5.15; P< .001) of incident insulin autoantibodies. In children with multiple autoantibodies, neither HOMA-IR nor rate of progression to Tanner Stage 4 were associated with progression to type 1 diabetes. Conclusion: Rapid weight gain during puberty is associated with development of islet autoimmunity. Puberty itself had no significant influence on the appearance of autoantibodies or type 1 diabetes. Further studies are needed to better understand the underlying mechanisms. Key Words: diabetes, p-cell, insulin resistance, type 1 diabetes Abbreviations: BMI, body mass index; GADA, glutamic acid decarboxylase; HLA, human leukocyte antigen; HOMA-IR, homeostasis model assessment of insulin resistance; mIAA, islet antibodies to insulin; TEDDY, The Environmental Determinants of Diabetes in the Young. Abstract Context The 2 peaks of type 1 diabetes incidence occur during early childhood and puberty. Objective We sought to better understand the relationship between puberty, islet autoimmunity, and type 1 diabetes. Methods The relationships between puberty, islet autoimmunity, and progression to type 1 diabetes were investigated prospectively in children followed in The Environmental Determinants of Diabetes in the Young (TEDDY) study. Onset of puberty was determined by subject self-assessment of Tanner stages. Associations between speed of pubertal progression, pubertal growth, weight gain, homeostasis model assessment of insulin resistance (HOMA-IR), islet autoimmunity, and progression to type 1 diabetes were assessed. The influence of individual factors was analyzed using Cox proportional hazard ratios. Results Out of 5677 children who were still in the study at age 8 years, 95% reported at least 1 Tanner Stage score and were included in the study. Children at puberty (Tanner Stage ≥2) had a lower risk (HR 0.65, 95% CI 0.45-0.93; P = .019) for incident autoimmunity than prepubertal children (Tanner Stage 1). An increase of body mass index Z-score was associated with a higher risk (HR 2.88, 95% CI 1.61-5.15; P < .001) of incident insulin autoantibodies. In children with multiple autoantibodies, neither HOMA-IR nor rate of progression to Tanner Stage 4 were associated with progression to type 1 diabetes. Conclusion Rapid weight gain during puberty is associated with development of islet autoimmunity. Puberty itself had no significant influence on the appearance of autoantibodies or type 1 diabetes. Further studies are needed to better understand the underlying mechanisms. The 2 peaks of type 1 diabetes incidence occur during early childhood and puberty. We sought to better understand the relationship between puberty, islet autoimmunity, and type 1 diabetes. The relationships between puberty, islet autoimmunity, and progression to type 1 diabetes were investigated prospectively in children followed in The Environmental Determinants of Diabetes in the Young (TEDDY) study. Onset of puberty was determined by subject self-assessment of Tanner stages. Associations between speed of pubertal progression, pubertal growth, weight gain, homeostasis model assessment of insulin resistance (HOMA-IR), islet autoimmunity, and progression to type 1 diabetes were assessed. The influence of individual factors was analyzed using Cox proportional hazard ratios. Out of 5677 children who were still in the study at age 8 years, 95% reported at least 1 Tanner Stage score and were included in the study. Children at puberty (Tanner Stage ≥2) had a lower risk (HR 0.65, 95% CI 0.45-0.93; = .019) for incident autoimmunity than prepubertal children (Tanner Stage 1). An increase of body mass index Z-score was associated with a higher risk (HR 2.88, 95% CI 1.61-5.15; < .001) of incident insulin autoantibodies. In children with multiple autoantibodies, neither HOMA-IR nor rate of progression to Tanner Stage 4 were associated with progression to type 1 diabetes. Rapid weight gain during puberty is associated with development of islet autoimmunity. Puberty itself had no significant influence on the appearance of autoantibodies or type 1 diabetes. Further studies are needed to better understand the underlying mechanisms. The 2 peaks of type 1 diabetes incidence occur during early childhood and puberty.ContextThe 2 peaks of type 1 diabetes incidence occur during early childhood and puberty.We sought to better understand the relationship between puberty, islet autoimmunity, and type 1 diabetes.ObjectiveWe sought to better understand the relationship between puberty, islet autoimmunity, and type 1 diabetes.The relationships between puberty, islet autoimmunity, and progression to type 1 diabetes were investigated prospectively in children followed in The Environmental Determinants of Diabetes in the Young (TEDDY) study. Onset of puberty was determined by subject self-assessment of Tanner stages. Associations between speed of pubertal progression, pubertal growth, weight gain, homeostasis model assessment of insulin resistance (HOMA-IR), islet autoimmunity, and progression to type 1 diabetes were assessed. The influence of individual factors was analyzed using Cox proportional hazard ratios.MethodsThe relationships between puberty, islet autoimmunity, and progression to type 1 diabetes were investigated prospectively in children followed in The Environmental Determinants of Diabetes in the Young (TEDDY) study. Onset of puberty was determined by subject self-assessment of Tanner stages. Associations between speed of pubertal progression, pubertal growth, weight gain, homeostasis model assessment of insulin resistance (HOMA-IR), islet autoimmunity, and progression to type 1 diabetes were assessed. The influence of individual factors was analyzed using Cox proportional hazard ratios.Out of 5677 children who were still in the study at age 8 years, 95% reported at least 1 Tanner Stage score and were included in the study. Children at puberty (Tanner Stage ≥2) had a lower risk (HR 0.65, 95% CI 0.45-0.93; P = .019) for incident autoimmunity than prepubertal children (Tanner Stage 1). An increase of body mass index Z-score was associated with a higher risk (HR 2.88, 95% CI 1.61-5.15; P < .001) of incident insulin autoantibodies. In children with multiple autoantibodies, neither HOMA-IR nor rate of progression to Tanner Stage 4 were associated with progression to type 1 diabetes.ResultsOut of 5677 children who were still in the study at age 8 years, 95% reported at least 1 Tanner Stage score and were included in the study. Children at puberty (Tanner Stage ≥2) had a lower risk (HR 0.65, 95% CI 0.45-0.93; P = .019) for incident autoimmunity than prepubertal children (Tanner Stage 1). An increase of body mass index Z-score was associated with a higher risk (HR 2.88, 95% CI 1.61-5.15; P < .001) of incident insulin autoantibodies. In children with multiple autoantibodies, neither HOMA-IR nor rate of progression to Tanner Stage 4 were associated with progression to type 1 diabetes.Rapid weight gain during puberty is associated with development of islet autoimmunity. Puberty itself had no significant influence on the appearance of autoantibodies or type 1 diabetes. Further studies are needed to better understand the underlying mechanisms.ConclusionRapid weight gain during puberty is associated with development of islet autoimmunity. Puberty itself had no significant influence on the appearance of autoantibodies or type 1 diabetes. Further studies are needed to better understand the underlying mechanisms.
Audience	Academic
Author	Veijola, Riitta McIndoe, Richard Ziegler, Anette-G Schatz, Desmond A Elding Larsson, Helena Warncke, Katharina Toppari, Jorma Hagopian, William Krischer, Jeffrey P Rewers, Marian J Tamura, Roy Akolkar, Beena Vehik, Kendra Haller, Michael J Lernmark, Åke Steck, Andrea K
Author_xml	– sequence: 1 givenname: Katharina orcidid: 0000-0003-1758-7656 surname: Warncke fullname: Warncke, Katharina email: katharina.warncke@mri.tum.de – sequence: 2 givenname: Roy surname: Tamura fullname: Tamura, Roy – sequence: 3 givenname: Desmond A surname: Schatz fullname: Schatz, Desmond A – sequence: 4 givenname: Riitta surname: Veijola fullname: Veijola, Riitta – sequence: 5 givenname: Andrea K orcidid: 0000-0002-5931-9484 surname: Steck fullname: Steck, Andrea K – sequence: 6 givenname: Beena surname: Akolkar fullname: Akolkar, Beena – sequence: 7 givenname: William surname: Hagopian fullname: Hagopian, William – sequence: 8 givenname: Jeffrey P orcidid: 0000-0003-4526-888X surname: Krischer fullname: Krischer, Jeffrey P – sequence: 9 givenname: Åke surname: Lernmark fullname: Lernmark, Åke – sequence: 10 givenname: Marian J surname: Rewers fullname: Rewers, Marian J – sequence: 11 givenname: Jorma surname: Toppari fullname: Toppari, Jorma – sequence: 12 givenname: Richard surname: McIndoe fullname: McIndoe, Richard – sequence: 13 givenname: Anette-G surname: Ziegler fullname: Ziegler, Anette-G – sequence: 14 givenname: Kendra orcidid: 0000-0001-6243-6772 surname: Vehik fullname: Vehik, Kendra – sequence: 15 givenname: Michael J surname: Haller fullname: Haller, Michael J – sequence: 16 givenname: Helena surname: Elding Larsson fullname: Elding Larsson, Helena
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/38867880$$D View this record in MEDLINE/PubMed
BookMark	eNqFUk1vEzEQXaEiWkKvHJElLnBIa6-99u4JRU2BSpWoRDhwGtne2dTVxl7Wu0H59zgk_QgCIR9sjd97M2_0XmZHPnjMsteMnrGc0fM79HUM52atkVH-LDvJhcqnrFL50ZP3cXYa4x2llFVcVEK8yI55WUpVlvQkWy9ukVz5ph3RWyShITejwX7QLZnjGtvQrdAPJHgyG4eg_eBMqDdk1nWoe72laF-Tmz4se4zRJdwQyGLTIWFk7rTBASNxqZraLC7n8-_k6zDWm1fZ80a3EU_39yT79vFycfF5ev3l09XF7HpqJaPDtC6K2liVF6Y0GhvBdW4qZWVeW2tVlfO6ospWuZWNakrGjOCFlNZUyR6qouGTTO9040_sRgNd71a630DQDrqwtQlp7mTF3kI7QkRIqNZZPSQrEURZFsoWOeS1YCAoZ1AVkkGtmbHUGtGk2iT7sOuRqCusbdpXn3QPWh38eHcLy7AGxphUad6k8G6v0IcfI8YBVi5abFvtMYwROJWqYoqLLfTtH9C7MPY-7RA4U1TyQknxiFrqFsH5JqTGdisKs5IKyYqUjoQ6-wsqnRpXzqaoNS7VDwhvnjp9sHgfpwQQO4DtQ4w9NmDd8HuXSdm1wChsgwu74MI-uI-DPNDulf9JeL8jhLH7H_YXDiwBZg
CitedBy_id	crossref_primary_10_1038_s41574_024_01045_0 crossref_primary_10_2337_dc24_2886
Cites_doi	10.2337/diacare.23.10.1516 10.1210/jc.2013-4455 10.1002/dmrr.2438 10.1007/s001250050514 10.2337/dc07-0103 10.1038/ijo.2011.122 10.1196/annals.1375.049 10.1542/peds.2014-0793 10.1007/s00125-004-1507-3 10.2337/dc21-0422 10.1007/s00125-012-2523-3 10.1111/pedi.12066 10.1111/dme.13295 10.1371/journal.pone.0260137 10.1093/biomet/80.1.27 10.2337/dc17-0238 10.1007/s00125-012-2472-x 10.1007/s10654-023-01002-7 10.2337/dc06-2389 10.1111/j.1399-5448.2007.00269.x 10.2307/2531910 10.1007/s001250100548 10.1196/annals.1447.062 10.2337/db17-0261 10.1016/j.immuni.2010.03.018
ContentType	Journal Article
Copyright	The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society. 2024 The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society. COPYRIGHT 2024 Oxford University Press The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml	– notice: The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society. 2024 – notice: The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society. – notice: COPYRIGHT 2024 Oxford University Press – notice: The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
CorporateAuthor	Lunds universitet Profile areas and other strong research environments Department of Clinical Sciences, Malmö Lund University Celiac Disease and Diabetes Unit Strategiska forskningsområden (SFO) EXODIAB: Excellence of Diabetes Research in Sweden Faculty of Medicine Celiaki och diabetes Strategic research areas (SRA) Medicinska fakulteten Profilområden och andra starka forskningsmiljöer Pediatrisk endokrinologi Institutionen för kliniska vetenskaper, Malmö Paediatric Endocrinology
CorporateAuthor_xml	– name: Faculty of Medicine – name: Medicinska fakulteten – name: Strategiska forskningsområden (SFO) – name: Celiaki och diabetes – name: Celiac Disease and Diabetes Unit – name: Institutionen för kliniska vetenskaper, Malmö – name: Strategic research areas (SRA) – name: Lunds universitet – name: Profilområden och andra starka forskningsmiljöer – name: Paediatric Endocrinology – name: Lund University – name: EXODIAB: Excellence of Diabetes Research in Sweden – name: Profile areas and other strong research environments – name: Pediatrisk endokrinologi – name: Department of Clinical Sciences, Malmö
DBID	TOX AAYXX CITATION NPM 3V. 7RV 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. KB0 M0S NAPCQ PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM ADTPV AGCHP AOWAS D8T D95 ZZAVC
DOI	10.1210/jendso/bvae103
DatabaseName	Oxford Journals Open Access Collection CrossRef PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection ProQuest Nursing & Allied Health Premium Proquest Central Premium ProQuest One Academic ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) SwePub SWEPUB Lunds universitet full text SwePub Articles SWEPUB Freely available online SWEPUB Lunds universitet SwePub Articles full text
DatabaseTitle	CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	Publicly Available Content Database PubMed MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: TOX name: Oxford Journals Open Access Collection url: https://academic.oup.com/journals/ sourceTypes: Publisher – sequence: 3 dbid: 7RV name: Nursing & Allied Health Database url: https://search.proquest.com/nahs sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	2472-1972
ExternalDocumentID	oai_portal_research_lu_se_publications_48857c52_2d41_4031_9561_da1bc0cb4f40 PMC11167566 A804615247 38867880 10_1210_jendso_bvae103 10.1210/jendso/bvae103
Genre	Journal Article
GeographicLocations	Germany
GeographicLocations_xml	– name: Germany
GrantInformation_xml	– fundername: ; – fundername: ; grantid: UL1 TR000064; UL1 TR002535
GroupedDBID	0R~ 53G 7RV 7X7 8FI 8FJ AAFWJ AAPXW AAVAP ABEJV ABGNP ABPTD ABUWG ABXVV ACGFS ADBBV AENZO AFKRA AFPKN ALMA_UNASSIGNED_HOLDINGS AMNDL AOIJS BAYMD BCNDV BENPR CCPQU EBS EJD EMOBN FYUFA GROUPED_DOAJ H13 HMCUK HYE IAO IHR ITC KQ8 KSI ML0 M~E NAPCQ O9- OK1 PHGZM PHGZT PIMPY RPM TJX TOX UKHRP AAYXX AFFHD CITATION PPXIY NPM 3V. 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PQEST PQQKQ PQUKI PRINS 7X8 PUEGO 5PM ADTPV AGCHP AOWAS D8T D95 ZZAVC
ID	FETCH-LOGICAL-c610t-d55dbc725b8baef43a2b97c62dccc7923d907c92c6f7f811b43566cb9867e75f3
IEDL.DBID	7RV
ISICitedReferencesCount	2
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001245159200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	2472-1972
IngestDate	Thu Nov 27 03:11:59 EST 2025 Tue Nov 04 02:05:28 EST 2025 Thu Sep 04 18:04:58 EDT 2025 Tue Oct 07 07:35:01 EDT 2025 Tue Nov 11 10:57:50 EST 2025 Sat Nov 29 10:33:17 EST 2025 Mon Jul 21 05:58:46 EDT 2025 Sat Nov 29 02:12:59 EST 2025 Tue Nov 18 21:25:34 EST 2025 Mon Jun 30 08:34:49 EDT 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	7
Keywords	type 1 diabetes β-cell diabetes insulin resistance
Language	English
License	This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. See the journal About page for additional terms. https://creativecommons.org/licenses/by/4.0 The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c610t-d55dbc725b8baef43a2b97c62dccc7923d907c92c6f7f811b43566cb9867e75f3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 M.J.H. and H.E.L. contributed equally to the article as joint last authors.
ORCID	0000-0003-4526-888X 0000-0002-5931-9484 0000-0003-1758-7656 0000-0001-6243-6772
OpenAccessLink	https://www.proquest.com/docview/3170635764?pq-origsite=%requestingapplication%
PMID	38867880
PQID	3170635764
PQPubID	7121343
ParticipantIDs	swepub_primary_oai_portal_research_lu_se_publications_48857c52_2d41_4031_9561_da1bc0cb4f40 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11167566 proquest_miscellaneous_3067917346 proquest_journals_3170635764 gale_infotracmisc_A804615247 gale_infotracacademiconefile_A804615247 pubmed_primary_38867880 crossref_citationtrail_10_1210_jendso_bvae103 crossref_primary_10_1210_jendso_bvae103 oup_primary_10_1210_jendso_bvae103
PublicationCentury	2000
PublicationDate	2024-07-01
PublicationDateYYYYMMDD	2024-07-01
PublicationDate_xml	– month: 07 year: 2024 text: 2024-07-01 day: 01
PublicationDecade	2020
PublicationPlace	US
PublicationPlace_xml	– name: US – name: United States – name: Oxford
PublicationTitle	Journal of the Endocrine Society
PublicationTitleAlternate	J Endocr Soc
PublicationYear	2024
Publisher	Oxford University Press
Publisher_xml	– name: Oxford University Press
References	Raab (2024070105125491100_bvae103-B10) 2013; 29 Carlsson (2024070105125491100_bvae103-B27) 2012; 36 Rewers (2024070105125491100_bvae103-B5) 1996; 39 Firth (2024070105125491100_bvae103-B20) 1993; 80 Krischer (2024070105125491100_bvae103-B24) 2017; 40 Lakatos (2024070105125491100_bvae103-B22) 1988; 44 Onda (2024070105125491100_bvae103-B4) 2017; 34 De Sanctis (2024070105125491100_bvae103-B17) 2016; 14 Parikka (2024070105125491100_bvae103-B1) 2012; 55 Wilkin (2024070105125491100_bvae103-B11) 2001; 44 Rollof (2024070105125491100_bvae103-B18) 2012; 25 Fourlanos (2024070105125491100_bvae103-B7) 2004; 47 Jaruratanasirikul (2024070105125491100_bvae103-B16) 2015; 28 Elding Larsson (2024070105125491100_bvae103-B29) 2014; 15 Krischer (2024070105125491100_bvae103-B19) 2017; 66 Xu (2024070105125491100_bvae103-B8) 2007; 30 Jacobsen (2024070105125491100_bvae103-B28) 2022; 45 Rasmussen (2024070105125491100_bvae103-B15) 2015; 135 TEDDY Study Group (2024070105125491100_bvae103-B13) 2007; 8 Kelly (2024070105125491100_bvae103-B21) 2014; 99 Bingley (2024070105125491100_bvae103-B9) 2008; 31 Hagopian (2024070105125491100_bvae103-B12) 2006; 1079 Syrjälä (2024070105125491100_bvae103-B26) 2021; 16 Ziegler (2024070105125491100_bvae103-B2) 2012; 55 Cantor (2024070105125491100_bvae103-B23) 2003 Peltonen (2024070105125491100_bvae103-B25) 2023; 38 Karvonen (2024070105125491100_bvae103-B3) 2000; 23 Ziegler (2024070105125491100_bvae103-B6) 2010; 32 TEDDY Study Group (2024070105125491100_bvae103-B14) 2008; 1150
References_xml	– volume: 28 start-page: 367 issue: 3–4 year: 2015 ident: 2024070105125491100_bvae103-B16 article-title: Reliability of pubertal maturation self-assessment in a school-based survey publication-title: J Pediatr Endocrinol Metab – volume: 23 start-page: 1516 issue: 10 year: 2000 ident: 2024070105125491100_bvae103-B3 article-title: Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) project group publication-title: Diabetes Care doi: 10.2337/diacare.23.10.1516 – volume: 14 start-page: 27 issue: 1 year: 2016 ident: 2024070105125491100_bvae103-B17 article-title: Methods for rating sexual development in girls publication-title: Pediatr Endocrinol Rev – volume: 99 start-page: 2104 issue: 6 year: 2014 ident: 2024070105125491100_bvae103-B21 article-title: Age-based reference ranges for annual height velocity in US children publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2013-4455 – volume: 29 start-page: 631 issue: 8 year: 2013 ident: 2024070105125491100_bvae103-B10 article-title: Continuous rise of insulin resistance before and after the onset of puberty in children at increased risk for type 1 diabetes—a cross-sectional analysis publication-title: Diabetes Metab Res Rev doi: 10.1002/dmrr.2438 – volume: 39 start-page: 807 issue: 7 year: 1996 ident: 2024070105125491100_bvae103-B5 article-title: Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY) publication-title: Diabetologia doi: 10.1007/s001250050514 – volume: 31 start-page: 146 issue: 1 year: 2008 ident: 2024070105125491100_bvae103-B9 article-title: Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT) publication-title: Diabetes Care doi: 10.2337/dc07-0103 – volume: 36 start-page: 718 issue: 5 year: 2012 ident: 2024070105125491100_bvae103-B27 article-title: Low risk HLA-DQ and increased body mass index in newly diagnosed type 1 diabetes children in the better diabetes diagnosis study in Sweden publication-title: Int J Obes (Lond) doi: 10.1038/ijo.2011.122 – volume: 1079 start-page: 320 year: 2006 ident: 2024070105125491100_bvae103-B12 article-title: TEDDY--The environmental determinants of diabetes in the young: an observational clinical trial publication-title: Ann N Y Acad Sci doi: 10.1196/annals.1375.049 – volume: 135 start-page: 86 issue: 1 year: 2015 ident: 2024070105125491100_bvae103-B15 article-title: Validity of self-assessment of pubertal maturation publication-title: Pediatrics doi: 10.1542/peds.2014-0793 – volume: 47 start-page: 1661 issue: 10 year: 2004 ident: 2024070105125491100_bvae103-B7 article-title: Insulin resistance is a risk factor for progression to type 1 diabetes publication-title: Diabetologia doi: 10.1007/s00125-004-1507-3 – volume: 25 start-page: 125 issue: 1–2 year: 2012 ident: 2024070105125491100_bvae103-B18 article-title: Evaluation of self-assessment of pubertal maturation in boys and girls using drawings and orchidometer publication-title: J Pediatr Endocrinol Metab – volume: 45 start-page: 624 issue: 3 year: 2022 ident: 2024070105125491100_bvae103-B28 article-title: Heterogeneity of DKA incidence and age-specific clinical characteristics in children diagnosed with type 1 diabetes in the TEDDY study publication-title: Diabetes Care doi: 10.2337/dc21-0422 – volume: 55 start-page: 1926 issue: 7 year: 2012 ident: 2024070105125491100_bvae103-B1 article-title: Early seroconversion and rapidly increasing autoautoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk publication-title: Diabetologia doi: 10.1007/s00125-012-2523-3 – volume-title: SAS Survival Analysis Techniques for Medical Research year: 2003 ident: 2024070105125491100_bvae103-B23 – volume: 15 start-page: 118 issue: 2 year: 2014 ident: 2024070105125491100_bvae103-B29 article-title: Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease publication-title: Pediatr Diabetes doi: 10.1111/pedi.12066 – volume: 34 start-page: 909 issue: 7 year: 2017 ident: 2024070105125491100_bvae103-B4 article-title: Incidence and prevalence of childhood-onset Type 1 diabetes in Japan: the T1D study publication-title: Diabet Med doi: 10.1111/dme.13295 – volume: 16 start-page: e0260137 issue: 11 year: 2021 ident: 2024070105125491100_bvae103-B26 article-title: Determining the timing of pubertal onset via a multicohort analysis of growth publication-title: PLoS One doi: 10.1371/journal.pone.0260137 – volume: 80 start-page: 27 year: 1993 ident: 2024070105125491100_bvae103-B20 article-title: Bias reduction of maximum likelihood estimates publication-title: Biometrika doi: 10.1093/biomet/80.1.27 – volume: 40 start-page: 1194 issue: 9 year: 2017 ident: 2024070105125491100_bvae103-B24 article-title: Genetic and environmental interactions modify the risk of diabetes-related autoimmunity by 6 years of age: the TEDDY study publication-title: Diabetes Care doi: 10.2337/dc17-0238 – volume: 55 start-page: 1937 issue: 7 year: 2012 ident: 2024070105125491100_bvae103-B2 article-title: Age-related islet autoautoantibody incidence in offspring of patients with type 1 diabetes publication-title: Diabetologia doi: 10.1007/s00125-012-2472-x – volume: 38 start-page: 689 issue: 6 year: 2023 ident: 2024070105125491100_bvae103-B25 article-title: What is the role of puberty in the development of islet autoimmunity and progression to type 1 diabetes? publication-title: Eur J Epidemiol doi: 10.1007/s10654-023-01002-7 – volume: 30 start-page: 2314 issue: 9 year: 2007 ident: 2024070105125491100_bvae103-B8 article-title: Role of insulin resistance in predicting progression to type 1 diabetes publication-title: Diabetes Care doi: 10.2337/dc06-2389 – volume: 8 start-page: 286 year: 2007 ident: 2024070105125491100_bvae103-B13 article-title: The environmental determinants of diabetes in the young (TEDDY) study: study design publication-title: Pediatr Diabetes doi: 10.1111/j.1399-5448.2007.00269.x – volume: 44 start-page: 229 year: 1988 ident: 2024070105125491100_bvae103-B22 article-title: Sample sizes based on the log rank statistic in Complex clinical trials publication-title: Biometrics doi: 10.2307/2531910 – volume: 44 start-page: 914 issue: 7 year: 2001 ident: 2024070105125491100_bvae103-B11 article-title: The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes publication-title: Diabetologia doi: 10.1007/s001250100548 – volume: 1150 start-page: 1 year: 2008 ident: 2024070105125491100_bvae103-B14 article-title: The environmental determinants of diabetes in the young (TEDDY) study publication-title: Ann N Y Acad Sci doi: 10.1196/annals.1447.062 – volume: 66 start-page: 3122 issue: 12 year: 2017 ident: 2024070105125491100_bvae103-B19 article-title: The influence of type 1 diabetes genetic susceptibility regions, age, sex, and family history on the progression from multiple autoantibodies to type 1 diabetes: a TEDDY study report publication-title: Diabetes doi: 10.2337/db17-0261 – volume: 32 start-page: 468 issue: 4 year: 2010 ident: 2024070105125491100_bvae103-B6 article-title: Prediction and pathogenesis in type 1 diabetes publication-title: Immunity doi: 10.1016/j.immuni.2010.03.018
SSID	ssj0001934944
Score	2.2751102
Snippet	Abstract Context The 2 peaks of type 1 diabetes incidence occur during early childhood and puberty. Objective We sought to better understand the relationship... The 2 peaks of type 1 diabetes incidence occur during early childhood and puberty. We sought to better understand the relationship between puberty, islet... Context: The 2 peaks of type 1 diabetes incidence occur during early childhood and puberty. Objective: We sought to better understand the relationship between... Context The 2 peaks of type 1 diabetes incidence occur during early childhood and puberty. Objective We sought to better understand the relationship between... The 2 peaks of type 1 diabetes incidence occur during early childhood and puberty.ContextThe 2 peaks of type 1 diabetes incidence occur during early childhood... CONTEXT: The 2 peaks of type 1 diabetes incidence occur during early childhood and puberty. OBJECTIVE: We sought to better understand the relationship between...
SourceID	swepub pubmedcentral proquest gale pubmed crossref oup
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	bvae103
SubjectTerms	Autoantibodies Clinical Clinical Medicine Development and progression Diabetes Endocrinology and Diabetes Endokrinologi och diabetes Health aspects Islands of Langerhans Klinisk medicin Medical and Health Sciences Medicin och hälsovetenskap Pediatric research Physiological aspects Puberty Type 1 diabetes
Title	The Influence of Pubertal Development on Autoantibody Appearance and Progression to Type 1 Diabetes in the TEDDY Study
URI	https://www.ncbi.nlm.nih.gov/pubmed/38867880 https://www.proquest.com/docview/3170635764 https://www.proquest.com/docview/3067917346 https://pubmed.ncbi.nlm.nih.gov/PMC11167566
Volume	8
WOSCitedRecordID	wos001245159200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2472-1972 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001934944 issn: 2472-1972 databaseCode: DOA dateStart: 20170101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2472-1972 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001934944 issn: 2472-1972 databaseCode: M~E dateStart: 20170101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVASL databaseName: Oxford Journals Open Access Collection customDbUrl: eissn: 2472-1972 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001934944 issn: 2472-1972 databaseCode: TOX dateStart: 20170101 isFulltext: true titleUrlDefault: https://academic.oup.com/journals/ providerName: Oxford University Press – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2472-1972 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001934944 issn: 2472-1972 databaseCode: 7X7 dateStart: 20170101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 2472-1972 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001934944 issn: 2472-1972 databaseCode: 7RV dateStart: 20170101 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2472-1972 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001934944 issn: 2472-1972 databaseCode: BENPR dateStart: 20170101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2472-1972 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001934944 issn: 2472-1972 databaseCode: PIMPY dateStart: 20170101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagRYgL70JgqQxC4hR17Tixc0ILtKKHLlFV0JaLFTu2uqhKlu5D6r9nJvFuN0LAgUukxE6cZD6Px-PxN4S8Zd4npUtk7I1H141wcalcEjNvhfQiN6UXbbIJOR6rySQvgsNtHsIq1zqxVdRVY9FHfpAgz0sC1rF4P_sZY9YoXF0NKTRuk12GYzfgWZ5-u_Gx5Ei-IgJXI25W-YFxps2BWZWOrfNkhbEoaOTeNrcta_P3oMketWg7HB09-N8PeUjuB0OUjjrkPCK3XP2Y3D0JS-1PyAoARI_XKUxo42mxxCBsuGcr0Ig2NR0tFw3IZ2qa6pqCVQt9B6FEy7qiBYZ_ddQfdNFQnPVSRkMYzpxO4So0A9rz0znFkMbrp-Tr0eHZx89xSNIQW7C8FnGVppWxkqdGmdJ5kZTc5NJmvLLWIjlhBdNvm3ObeekVYwbssyyzJleZdDL1yR7ZqZvaPSeUW25VBniBWZLwmVJVyRxPS4mUrbkcRiRei0vbwGCOiTQuNc5kQLy6E68O4o3Iu039Wcfd8eeaKH2NnRqeaMuwNwHeC-mx9EghL33KhYzIoFcTOqPtFb8B_PyztcEaGTpojLm-gUVEXm-K8fEYBVe7Zgl10OvHZCKyiDzr0LhpKlHwQ0EZR0T1cLqpgDzi_ZJ6etHyiTNciwOhROR7B-n-Pe00UAfuqQt9udRzp2dbTmUNg0Aqbco1rwTTAsYJjfulNcjP2KE1wovhi79_9Etyj4O52AVCD8jO4mrpXpE7drWYzq_2226Nx4lsj2qf7H44HBen-60PBc6K45PiHM7Ovkx-Ae0eYvo
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFLbGQMAL90uggEEgnqI1jhM7DwhVjGnVtqoPQxq8mNixtaIpKesF9U_xGzkncbpGCHjaA6-1Y9fxuTqfv0PI68i5OLexCJ12eHTDbZhLG4eRM1w4nunc8brYhBiN5MlJNt4iP9u7MAirbG1ibaiLyuAZ-U6MPC8xRMf8_fR7iFWj8OtqW0KjEYsDu_oBKdvs3XAX9vcNY3sfjz_sh76qQGggVJiHRZIU2giWaKlz63icM50Jk7LCGINsegXkiyZjJnXCySjSEFCkqdGZTIUViYth3CvkKthxgRAycSIuznQyJHvhnhsSL8d8Q1xrtaOXuY3aulze93kP0LlWtxHd_g7S7FCZ1u5v7_b_9uLukFs-0KaDRjPuki1b3iPXjzyU4D5ZgoLQYVuihVaOjhcIModnNoBUtCrpYDGvQP4muipWFKJ2WAuqCs3Lgo4R3tZQm9B5RTGrpxH1MKMZncCvMA14h93PFCGbqwfk06Ws-iHZLqvSPiaUGWZkCvoAWSB3qZRFHlmW5AIpaTPRD0jYiocynqEdC4WcKczUQJxUI07Ki1NA3q77Txtukj_3RGlTaLRgRJP7uxfwv5D-Sw0k8u4njIuA9Do9wdiYTvMrkNd_ztZrJVF5izhTF2IYkJfrZhweUX6lrRbQB081IxHzNCCPGulfTxVLeKHgbAIiO3qx7oA86d2WcnJa86VH-K0RNiUgXxoV6j5Tp7nKc2udqrOFmlk13Tg0V-DkEmESpljBI8XBDyq8D65g_7TpG80d7z_5-6JfkBv7x0eH6nA4OnhKbjIIjRvQd49sz88X9hm5Zpbzyez8eW1SKPl62ar4C5T8ua0
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Influence+of+Pubertal+Development+on+Autoantibody+Appearance+and+Progression+to+Type+1+Diabetes+in+the+TEDDY+Study&rft.jtitle=Journal+of+the+Endocrine+Society&rft.au=Warncke%2C+Katharina&rft.au=Tamura%2C+Roy&rft.au=Schatz%2C+Desmond+A&rft.au=Veijola%2C+Riitta&rft.date=2024-07-01&rft.issn=2472-1972&rft.eissn=2472-1972&rft.volume=8&rft.issue=7&rft_id=info:doi/10.1210%2Fjendso%2Fbvae103&rft.externalDocID=oai_portal_research_lu_se_publications_48857c52_2d41_4031_9561_da1bc0cb4f40
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2472-1972&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2472-1972&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2472-1972&client=summon